Which of the following is essential for effective pharmacovigilance in special populations such as pediatrics or geriatrics?
1
Avoiding any medication use in these populations
2
Conducting specific studies to understand drug safety in these populations
3
Treating these populations the same as general adult populations
4
Not reporting ADRs for these groups